CAPR
CapricorยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CAPR Profile
Capricor Therapeutics, Inc.
A company that developing regenerative medicine and large molecule products to treat heart failure
10865 Road to the Cure, Suite 150, San Diego, California 92121
--
Capricor Therapeutics, Inc., is incorporated in Delaware. The Company is a clinical-stage biotechnology company focused on developing transformational cell and exosome-based therapies for the treatment of Duchenne muscular dystrophy (" DMD "), a rare form of muscular dystrophy that leads to muscle degeneration and premature death, as well as a disease with high unmet medical needs.
